What does Royalty Pharma Sub-Manager, LLC hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Royalty Pharma Sub-Manager, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

CYTOKINETICS, INC

$65M980K37.4%

ZENAS BIOPHARMA, INC.

$47M2.4M27.0%

BIOCRYST PHARMACEUTICALS INC

$37M3.8M21.2%

BIOHAVEN LTD

$25M2.9M14.4%

Filing history loading…